Patents by Inventor Mi Hwa OH

Mi Hwa OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-INFLAMMATORY COMPOSITION COMPRISING EPIMENDIUM KOREANUM NAKAI, POLYGALA TENUIFOLIA WILD, AND POLYPORUS UMBELLATUS FRIES EXTRACTS OR MIXTURE THEREOF AS ACTIVE INGREDIENT
    Publication number: 20240148810
    Abstract: The present invention relates to an anti-inflammatory composition comprising Epimedium koreanum Nakai, Polygala tenuifolia Willd, and Polyporus umbellatus Fries extracts or a mixture thereof as an active ingredient. The extracts and mixture prepared according to the present invention exhibit a high inhibitory effect against nitric oxide and a suppressive effect against the expression of iNOS and COX2 and thus can be advantageously used as an anti-inflammatory composition.
    Type: Application
    Filed: March 19, 2021
    Publication date: May 9, 2024
    Applicant: Korea Research Institute of Chemical Technology
    Inventors: Hyoung-Yun Han, Jung-Hwa Oh, Seokjoo Yoon, Se-Myo Park, Mi-Sun Choi, Soojin Kim
  • Display device
    Patent number: 11935481
    Abstract: Provided is a display device, which includes: a reference voltage line formed along a circular outer line and configured to provide a reference voltage; a first reference voltage auxiliary line electrically connected to the reference voltage line and formed to be parallel with a predetermined interval; and a conductive line forming a contact with the reference voltage line and the first reference voltage auxiliary line and configured to provide the reference voltage to a cathode.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: March 19, 2024
    Assignee: Samsung Display Co., Ltd.
    Inventors: Seung Han Jo, Min Chae Kwak, Kyeong Hwa Kim, Mi Hae Kim, Kyong Hwan Oh, Su Mi Jang, Jae-Ho Choi
  • PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND
    Publication number: 20220125764
    Abstract: The present invention relates to a pharmaceutical composition for preventing the recurrence of gastroesophageal reflux disease, comprising a benzimidazole derivative. The pharmaceutical composition of the present invention may effectively prevent the recurrence of gastroesophageal reflux disease without any side effects for a long period of time.
    Type: Application
    Filed: February 17, 2020
    Publication date: April 28, 2022
    Applicant: HK INNO.N CORPORATION
    Inventors: Bong Tae KIM, Hyun Kyung LEE, Ji Yeon NAM, Mi Hwa OH, Geun Seog SONG, Myeongjoong KIM